EPS Bio Technology Corp. (TPEX:4183)
Taiwan
· Delayed Price · Currency is TWD 14.10
-0.10 (-0.70%)
Apr 29, 2026, 1:30 PM CST
EPS Bio Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -7.87 | 17.31 | 20.99 | 25.36 | 18.64 | Upgrade
|
| Depreciation & Amortization | 15.38 | 14.18 | 14.9 | 16.62 | 17.85 | Upgrade
|
| Other Amortization | - | 0.42 | 0.6 | 0.69 | 0.73 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | - | 0.26 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.65 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 2.6 | -1.89 | 0.16 | 2.61 | 1.2 | Upgrade
|
| Other Operating Activities | -1.63 | -15.52 | 5.45 | -10.33 | 7.63 | Upgrade
|
| Change in Accounts Receivable | -3.35 | -51.18 | -17.08 | 20.8 | -21.49 | Upgrade
|
| Change in Inventory | 7.17 | -8.39 | 10.86 | -4.89 | -35.46 | Upgrade
|
| Change in Accounts Payable | -7.85 | 5.84 | 16.42 | -23.15 | 24.82 | Upgrade
|
| Change in Unearned Revenue | -5.37 | 9.96 | 3.97 | -27.69 | 22.7 | Upgrade
|
| Change in Other Net Operating Assets | 0.87 | -3.07 | -1.35 | 4.98 | -4.54 | Upgrade
|
| Operating Cash Flow | 0.6 | -32.34 | 55.17 | 5 | 32.08 | Upgrade
|
| Operating Cash Flow Growth | - | - | 1003.86% | -84.42% | -59.85% | Upgrade
|
| Capital Expenditures | -22.36 | -13.9 | -9.48 | -14.95 | -11.75 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.01 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1.61 | -0.51 | - | - | -0.39 | Upgrade
|
| Other Investing Activities | - | - | - | 0.04 | - | Upgrade
|
| Investing Cash Flow | -23.97 | -14.4 | -9.48 | -14.92 | -12.14 | Upgrade
|
| Short-Term Debt Issued | 50 | - | - | - | - | Upgrade
|
| Total Debt Issued | 50 | - | - | - | - | Upgrade
|
| Short-Term Debt Repaid | -10 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -6.06 | -5.68 | -5.59 | -5.93 | -5.46 | Upgrade
|
| Total Debt Repaid | -16.06 | -5.68 | -5.59 | -5.93 | -5.46 | Upgrade
|
| Net Debt Issued (Repaid) | 33.94 | -5.68 | -5.59 | -5.93 | -5.46 | Upgrade
|
| Common Dividends Paid | -15.95 | -19.04 | -23.32 | -16.66 | -28.56 | Upgrade
|
| Financing Cash Flow | 18 | -24.72 | -28.91 | -22.59 | -34.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.49 | 5.11 | -0.15 | 7.75 | -4.38 | Upgrade
|
| Net Cash Flow | -5.86 | -66.35 | 16.63 | -24.76 | -18.45 | Upgrade
|
| Free Cash Flow | -21.76 | -46.24 | 45.69 | -9.96 | 20.34 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -72.30% | Upgrade
|
| Free Cash Flow Margin | -4.35% | -10.25% | 9.72% | -2.15% | 4.23% | Upgrade
|
| Free Cash Flow Per Share | -0.91 | -1.94 | 1.91 | -0.42 | 0.85 | Upgrade
|
| Cash Interest Paid | 1.9 | 2.05 | 2.14 | 2.13 | 2.18 | Upgrade
|
| Cash Income Tax Paid | 0.64 | 6.59 | 6.48 | 3.77 | 4.32 | Upgrade
|
| Levered Free Cash Flow | -21.37 | -60.98 | 39.95 | -22.31 | 15.26 | Upgrade
|
| Unlevered Free Cash Flow | -20.18 | -59.7 | 41.29 | -20.98 | 16.63 | Upgrade
|
| Change in Working Capital | -8.53 | -46.84 | 12.82 | -29.94 | -13.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.